Please ensure Javascript is enabled for purposes of website accessibility

Microsoft Joins Alliance to Collect Plasma from Recovered COVID-19 Patients

By Donna Fuscaldo - Apr 20, 2020 at 11:07AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This weekend, the tech giant rolled out an online chatbot that encourages people who can to donate their blood plasma to the effort to develop a coronavirus treatment.

As part of the effort to develop treatments for people with severe cases of COVID-19, Microsoft (MSFT 1.70%) and the Bill and Melinda Gates Foundation are teaming up with the CoVIg-19 Plasma Alliance to encourage people who have recovered from the coronavirus to donate their blood plasma. That "convalescent plasma" contains antibodies that can be concentrated into an immune globulin (the "Ig" in the alliance's name) that it is hoped will prove effective against the coronavirus.

"The sooner recovered COVID-19 patients donate convalescent plasma, the sooner the Alliance may be able to start manufacturing a potential therapy and begin clinical trials," the group wrote in a blog post. "These trials will determine if this therapy could treat patients who are at risk for serious complications from COVID-19."

A medical profession wearing a mask and gloves holding a vial of blood.


Microsoft is providing technological support for the effort, and also developed what it calls a plasmabot -- an online chatbot that will encourage people to volunteer to donate plasma. The chatbot will walk people through several questions to determine if they're candidates for the program, and if they are, direct them to the closest licensed plasma collection center. The plasmabot launched this weekend. 

Peter Lee, the head of research at Microsoft, told CNBC in an interview that the group is aiming to recruit as many donors as possible, as quickly as it can. He noted that there's only a brief window of time after a person recovers from an illness when their plasma could be useful in creating an immune globulin treatment for it. In addition to creating the plasmabot, Microsoft is providing computing resources, infrastructure, and engineers to  the CoVIg-19 Plasma Alliance. 

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. Donna Fuscaldo has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Microsoft and recommends the following options: long January 2021 $85 calls on Microsoft and short January 2021 $115 calls on Microsoft. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Microsoft Corporation Stock Quote
Microsoft Corporation
$291.91 (1.70%) $4.89

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.